Signal regulatory protein α (SIRPα) is a critical immune inhibitory receptor on macrophages, and its interaction with CD47 prevents autologous phagocytosis. We have previously shown that pig CD47 does not interact with human SIRPα, and that human CD47 expression inhibits phagocytosis of porcine cells by human macrophages in vitro. In this study, we have investigated the potential of human CD47 expression to promote porcine cell survival in vivo. Human CD47-expressing and control porcine B-lymphoma cells were transplanted into T-and B-cell-deficient nonobese diabetic/severe combined immunodeficient (NOD/ SCID) mice that express SIRPα capable of interacting with human CD47. Only the human CD47-expressing porcine lymphoma cells survived and were able to form tumors in NOD/SCID mice; however, both the control and human CD47-expressing porcine cells survived in macrophage-depleted NOD/SCID mice. These results indicate that transgenic expression of human CD47 may provide an effective approach to inhibiting macrophage-mediated xenograft rejection in clinical xenotransplantation.
INTRODUCTION
after xenotransplantation, and their responses to xenoantigens occur before T-cell activation (10) . Macrophages cause almost immediate rejection of xenogeneic bone Xenotransplantation from pigs may provide a solution to the scarcity of human donors, but this type of marrow cells, even in the absence of adaptive immunity (1,3), which poses a formidable obstacle to the applica-clinical translation is primarily hampered by strong xenoimmune responses (7, 16, 20, 28) . Because of the exten-tion of mixed chimerism for induction of xenotransplantation tolerance. Macrophages have also been found to sive molecular incompatibilities between the donor and host, innate immune responses, including those medi-mediate the rejection of porcine islet xenografts in both rodents (9, 11, 17, 26) and primates (19) . ated by natural antibodies, complement, macrophages, and natural killer (NK) cells, play a much greater role Macrophage activation is regulated by the balance between stimulatory and inhibitory signals. CD47 (also in the rejection of xenografts than in allograft rejection. Recipient macrophages are activated and rapidly recruited known as the integrin-associated protein) is a member of the Ig superfamily and it is expressed ubiquitously in Porcine Cell Transplantation in NOD/SCID Mice all tissues (5) . Signaling regulatory protein α (SIRPα) Porcine cells were injected into the peritoneal cavity (also known as CD172a or SHPS-1) is an inhibitory or renal subcapsular space of NOD/SCID mice. Some receptor expressed on macrophages and dendritic cells NOD/SCID mice were treated with clodronate lipo-(DCs) that recognizes CD47 as a "marker of self" (2,5).
somes to deplete macrophages. Clodronate was a gift The CD47-SIRPα interaction provides a "don't eat me" from Roche Diagnostics GmbH (Mannheim, Germany), signal to macrophages, which is required for preventing and liposome encapsulation was performed as described phagocytosis of normal self-hematopoietic cells. We previously (22). NOD/SCID mice were intravenously have recently shown that the lack of interaction between injected with clodronate liposomes every 5 days until pig CD47 and mouse SIRPα is critically associated with analysis. Porcine cell survival was determined by flow macrophage-mediated xenograft rejection in mice (24) . cytometric analysis (FACScalibur; BD Biosciences, San We also observed that pig CD47 does not functionally Jose, CA) using fluorescence-conjugated anti-pMHC-I interact with human SIRPα, and that human CD47 (clone 2.27.3) and anti-human CD47 (B6H12). Each expression reduces phagocytosis of porcine cells by experimental group contained between 3 and 12 mice. human macrophages in vitro (12) . A recent study demonstrated that, due to polymorphisms in the nonobese Statistical Analysis diabetic (NOD) SIRPα allele, NOD mouse SIRPα is Significant differences between groups were detercapable of cross-reacting with human CD47, and such mined by Student's t-test using Prism 4 (GraphPad Softcross-reactivity prevents human hematopoietic cells ware, San Diego, CA). A value of p < 0.05 was considfrom rejection by macrophages in the mouse model (21) . ered statistically significant. In the present study, we used NOD/SCID (severe combined immunodeficient) mice to assess the potential of RESULTS human CD47 expression to inhibit macrophage-medi-Human CD47 Expression Enables Porcine LCL Cells ated rejection of porcine cells in vivo.
to Survive in NOD/SCID Mice
MATERIALS AND METHODS
We first compared the survival of hCD47-LCL and Mice and Cell Lines pKS-LCL) porcine LCL cells in NOD/SCID mice after IP injection. In vitro assay confirmed that hCD47-LCL Nonobese diabetic/severe combined immunodeficient cells are significantly more resistant than pKS-LCL cells (NOD/SCID) mice were purchased from The Jackson to destruction by human macrophages (Fig. 1 ), which is Laboratory (Bar Harbor, ME), and housed in a specific consistent with our previous observations (12) . NOD/ pathogen-free microisolator environment. Protocols in-SCID mice were injected IP with the 1:1 mixed hCD47volving animals used in this study were approved by the LCL and pKS-LCL cells (5 × 10 7 /mouse in total) (Fig. Massachusetts General Hospital Subcommittee of Re-2A), and sacrificed either when they first showed signs search Animal Care, and all of the experiments were consistent with tumor development (lethargy, hunched performed accordingly. Human CD47-expressing (hCD47posture, weight loss, and palpable abdominal swelling LCL) and control (pKS-LCL) porcine cell lines were and/or mass) or at day 45 postinjection. In the 12 mice generated by transfecting porcine B lymphoma cell line examined, five developed visible tumors ( Fig. 2B ). (LCL) cells with pKS336-hCD47 or empty pKS336 vec-Tumor cell suspensions were subsequently prepared and tor, respectively, as described previously (12) .
stained with anti-pig class I and anti-human CD47 in In Vitro Cytotoxicity Assay order to detect the survival of hCD47-LCL versus pKS-LCL cells. Flow cytometric analysis of the tumor cell hCD47-LCL cells and pKS-LCL cells were mixed (at 1:1 ratio) and cocultured (4 × 10 4 /well) with or without suspensions revealed that all tumor cells from these mice expressed human CD47, indicating that hCD47-human macrophages in 24-well plates, and the ratios of hCD47-LCL cells to pKS-LCL cells in the cultures were LCL, but not pKS-LCL, cells were capable of surviving in NOD/SCID mice (Table 1 , Fig. 2B ). determined every day for 8 days by flow cytometry using anti-human CD47 mAb (B6H12; Pharmingen, San Similar results were obtained when a mixture (1:1) of hCD47-LCL and pKS-LCL cells was injected into the Diego, CA) and anti-pig major histocompatibility complex class I (pMHC-I; clone 2.27.3). Human macro-renal subcapsular space of NOD/SCID mice. These mice were sacrificed between 2 and 5 weeks after LCL cell phages were differentiated from human monocytic leukemia cell line THP-1 cells (ATCC, Manassas, VA) by injection, and tumors were found in four of the five mice analyzed (Table 1) . Again, all surviving tumor cells stimulation with phorbol myristate acetate (100 ng/ml) for 2 days, and were used after washing out the nonad-detected in these mice were determined to be human CD47 + hCD47-LCL cells by flow cytometric analysis herent cells. using anti-human CD47 mAb (Table 1, Fig. 2C, D) .
indicate that porcine LCL cells are susceptible to rejection by macrophages, and that human CD47 expression These results clearly show that human CD47 expression is capable of markedly improving the survival of porcine is capable of preventing LCL cells from destruction by macrophages in NOD/SCID mice. LCL cells in NOD/SCID mice.
Recipient Macrophages Are Responsible for the DISCUSSION

Rejection of Porcine LCL Cells in NOD/SCID Mice
In the study presented herein, we show that human CD47-expressing porcine LCL cells can survive as To determine whether the observed advantage of hCD47-LCL cells over pKS-LCL cells to survive in xenografts in NOD/SCID mice. However, both human CD47-expressing and control porcine LCL cells were NOD/SCID mice was due to protection against phagocytosis by human CD47 expression, we next compared able to survive in macrophage-depleted NOD/SCID mice, demonstrating that human CD47 expression was the survival of these cells in macrophage-depleted NOD/ SCID mice. Macrophage depletion was achieved by injec-able to prevent porcine cells from being rejected via destruction by recipient macrophages. Because NOD/ tion of clodronate liposomes as previously described (1,23). NOD/SCID mice were treated with clodronate SCID mouse SIRPα is known to be capable of interacting with human CD47 (21), these results indicated that liposomes every 5 days; 3 days after the first injection of clodronate liposomes, hCD47-LCL and pKS-LCL cells the protective effect of human CD47 expression is likely mediated through a SIRPα-related mechanism providing were injected into the subcapsular space of left and right kidney, respectively. These mice were sacrificed 5 inhibitory signals to recipient macrophages. Further studies using SIRPα blockades or SIRPα-deficient weeks later and all had developed large tumors on both kidneys (n = 3) (Fig. 3A, B) . Flow cytometric analysis recipients are needed to draw a conclusion. We had previously reported that porcine hematopoi-of excised tumor cell suspensions demonstrated that the tumors on the left and right kidneys were formed by the etic chimerism can be established in triple porcine cytokine [interleukin 3 (IL-3), granulocyte-macrophage col-respectively injected hCD47-LCL and pKS-LCL cells (Fig. 3C) . Despite the relatively small number of mice ony stimulating factor (GM-CSF), and stem cell factor (SCF)] transgenic NOD/SCID mice after administration examined, this result provides strong evidence that pKS-LCL cells are capable of surviving in macrophage-of large numbers of porcine bone marrow cells (approximately 1 × 10 8 /mouse) and peripheral blood mononu-depleted NOD/SCID mice. Taken together, our data clear cells (about 5 × 10 7 /mouse) (6) . However, almost also be a consequence of macrophage-mediated rejection, as porcine T and B cells have been shown to sur-all surviving porcine cells in the long-term chimeric mice were found to be CD172a + myeloid cells. Although vive in macrophage-depleted mice (1). Support for the latter possibility is provided by studies using mouse the lack of porcine T and B cells in the chimeric mice could possibly be due to the inability of porcine lym-bone marrow chimeras in which we recently observed that CD47 knock out (KO) macrophage-1 antigen-pos-phoid cell differentiation to occur in mice, this could itve (Mac-1 + ) myeloid cells are significantly more resis-CD47 could be advantageous as donors for clinical xenotransplantation. CD47-SIRPα signaling also plays an tant to rejection by macrophages than lymphoid cells (23). In that study, mixed bone marrow chimeras were important role in the control of dendritic cell maturation and activation (4, 23) . Our recent studies demonstrated established by injection of CD47 KO bone marrow cells into sublethally irradiated wild-type mice after transient that CD47 expression on donor cells is required to repress recipient dendritic cell activation and suppress allograft macrophage depletion. Although initial engraftment of CD47 KO cells was achieved in these mice, the levels rejection after donor-specific transfusion (25) . Thus, it is possible that xenografts from human CD47 transgenic of CD47 KO donor chimerism declined rapidly after transplantation. Of note, Mac-1 + CD47 KO cells were pigs may also have a reduced potency to stimulate adaptive xenoimmune responses, and this hypothesis merits rejected at a significantly slower rate than CD47 KO lymphoid cells and remained detectable for approxi-further study. mately 30 weeks.
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